nodes	percent_of_prediction	percent_of_DWPC	metapath
Duloxetine—HTR2A—pancreatitis	0.636	1	CbGaD
Duloxetine—Impaired gastric emptying—Hyoscyamine—pancreatitis	0.014	0.0644	CcSEcCtD
Duloxetine—Urinary hesitation—Propantheline—pancreatitis	0.0122	0.056	CcSEcCtD
Duloxetine—Angle closure glaucoma—Hyoscyamine—pancreatitis	0.00951	0.0436	CcSEcCtD
Duloxetine—Cinacalcet—CASR—pancreatitis	0.00849	0.875	CrCbGaD
Duloxetine—Arrhythmia supraventricular—Hyoscyamine—pancreatitis	0.00661	0.0303	CcSEcCtD
Duloxetine—Mydriasis—Propantheline—pancreatitis	0.00627	0.0288	CcSEcCtD
Duloxetine—Urinary hesitation—Hyoscyamine—pancreatitis	0.00624	0.0287	CcSEcCtD
Duloxetine—Loss of libido—Hyoscyamine—pancreatitis	0.00555	0.0255	CcSEcCtD
Duloxetine—Supraventricular tachycardia—Hyoscyamine—pancreatitis	0.00391	0.0179	CcSEcCtD
Duloxetine—Thirst—Propantheline—pancreatitis	0.00382	0.0175	CcSEcCtD
Duloxetine—Laryngitis—Hyoscyamine—pancreatitis	0.00355	0.0163	CcSEcCtD
Duloxetine—Mania—Hyoscyamine—pancreatitis	0.00352	0.0162	CcSEcCtD
Duloxetine—Ventricular arrhythmia—Hyoscyamine—pancreatitis	0.00346	0.0159	CcSEcCtD
Duloxetine—Rash erythematous—Hyoscyamine—pancreatitis	0.00334	0.0153	CcSEcCtD
Duloxetine—Feeling hot—Hyoscyamine—pancreatitis	0.00326	0.015	CcSEcCtD
Duloxetine—Mydriasis—Hyoscyamine—pancreatitis	0.00321	0.0147	CcSEcCtD
Duloxetine—Dysphagia—Propantheline—pancreatitis	0.00314	0.0144	CcSEcCtD
Duloxetine—Blood disorder—Hyoscyamine—pancreatitis	0.00307	0.0141	CcSEcCtD
Duloxetine—Erectile dysfunction—Propantheline—pancreatitis	0.00289	0.0133	CcSEcCtD
Duloxetine—Dysarthria—Hyoscyamine—pancreatitis	0.00271	0.0124	CcSEcCtD
Duloxetine—Muscle twitching—Hyoscyamine—pancreatitis	0.00261	0.012	CcSEcCtD
Duloxetine—Blood pressure increased—Hyoscyamine—pancreatitis	0.00256	0.0118	CcSEcCtD
Duloxetine—Dermatitis contact—Hyoscyamine—pancreatitis	0.00253	0.0116	CcSEcCtD
Duloxetine—Dry eye—Hyoscyamine—pancreatitis	0.00237	0.0109	CcSEcCtD
Duloxetine—Flushing—Propantheline—pancreatitis	0.00233	0.0107	CcSEcCtD
Duloxetine—Tension—Propantheline—pancreatitis	0.00215	0.00985	CcSEcCtD
Duloxetine—Nervousness—Propantheline—pancreatitis	0.00212	0.00975	CcSEcCtD
Duloxetine—Disorientation—Hyoscyamine—pancreatitis	0.00208	0.00954	CcSEcCtD
Duloxetine—Eczema—Hyoscyamine—pancreatitis	0.00207	0.00949	CcSEcCtD
Duloxetine—Vision blurred—Propantheline—pancreatitis	0.00206	0.00946	CcSEcCtD
Duloxetine—Atrial fibrillation—Hyoscyamine—pancreatitis	0.00196	0.009	CcSEcCtD
Duloxetine—Thirst—Hyoscyamine—pancreatitis	0.00195	0.00897	CcSEcCtD
Duloxetine—Palpitations—Propantheline—pancreatitis	0.00193	0.00887	CcSEcCtD
Duloxetine—Hypoglycaemia—Hyoscyamine—pancreatitis	0.00191	0.00874	CcSEcCtD
Duloxetine—Lethargy—Hyoscyamine—pancreatitis	0.0019	0.00871	CcSEcCtD
Duloxetine—Hyponatraemia—Hyoscyamine—pancreatitis	0.00187	0.00857	CcSEcCtD
Duloxetine—Osteoarthritis—Hyoscyamine—pancreatitis	0.00186	0.00853	CcSEcCtD
Duloxetine—Dry mouth—Propantheline—pancreatitis	0.00182	0.00836	CcSEcCtD
Duloxetine—Confusional state—Propantheline—pancreatitis	0.0018	0.00826	CcSEcCtD
Duloxetine—Anaphylactic shock—Propantheline—pancreatitis	0.00179	0.00819	CcSEcCtD
Duloxetine—Irritability—Hyoscyamine—pancreatitis	0.00177	0.00814	CcSEcCtD
Duloxetine—Urinary retention—Hyoscyamine—pancreatitis	0.00177	0.00811	CcSEcCtD
Duloxetine—Ataxia—Hyoscyamine—pancreatitis	0.00175	0.00802	CcSEcCtD
Duloxetine—Tachycardia—Propantheline—pancreatitis	0.00174	0.00799	CcSEcCtD
Duloxetine—Dehydration—Hyoscyamine—pancreatitis	0.00173	0.00793	CcSEcCtD
Duloxetine—Insomnia—Propantheline—pancreatitis	0.00161	0.00741	CcSEcCtD
Duloxetine—Dysphagia—Hyoscyamine—pancreatitis	0.00161	0.00737	CcSEcCtD
Duloxetine—Somnolence—Propantheline—pancreatitis	0.00159	0.00728	CcSEcCtD
Duloxetine—Constipation—Propantheline—pancreatitis	0.00153	0.00701	CcSEcCtD
Duloxetine—Dysuria—Hyoscyamine—pancreatitis	0.0015	0.0069	CcSEcCtD
Duloxetine—Erectile dysfunction—Hyoscyamine—pancreatitis	0.00148	0.00679	CcSEcCtD
Duloxetine—Feeling abnormal—Propantheline—pancreatitis	0.00147	0.00675	CcSEcCtD
Duloxetine—Hyperglycaemia—Hyoscyamine—pancreatitis	0.00145	0.00665	CcSEcCtD
Duloxetine—Urticaria—Propantheline—pancreatitis	0.00142	0.00651	CcSEcCtD
Duloxetine—Acute coronary syndrome—Hyoscyamine—pancreatitis	0.00141	0.00648	CcSEcCtD
Duloxetine—Myocardial infarction—Hyoscyamine—pancreatitis	0.0014	0.00645	CcSEcCtD
Duloxetine—Conjunctivitis—Hyoscyamine—pancreatitis	0.00139	0.00639	CcSEcCtD
Duloxetine—Hypersensitivity—Propantheline—pancreatitis	0.00132	0.00604	CcSEcCtD
Duloxetine—Asthenia—Propantheline—pancreatitis	0.00128	0.00588	CcSEcCtD
Duloxetine—Hallucination—Hyoscyamine—pancreatitis	0.00128	0.00587	CcSEcCtD
Duloxetine—Flushing—Hyoscyamine—pancreatitis	0.00119	0.00548	CcSEcCtD
Duloxetine—Dizziness—Propantheline—pancreatitis	0.00118	0.00542	CcSEcCtD
Duloxetine—Arrhythmia—Hyoscyamine—pancreatitis	0.00115	0.00527	CcSEcCtD
Duloxetine—Vomiting—Propantheline—pancreatitis	0.00113	0.00521	CcSEcCtD
Duloxetine—Mental disorder—Hyoscyamine—pancreatitis	0.00113	0.00517	CcSEcCtD
Duloxetine—Rash—Propantheline—pancreatitis	0.00113	0.00517	CcSEcCtD
Duloxetine—Dermatitis—Propantheline—pancreatitis	0.00112	0.00516	CcSEcCtD
Duloxetine—Erythema—Hyoscyamine—pancreatitis	0.00112	0.00514	CcSEcCtD
Duloxetine—Headache—Propantheline—pancreatitis	0.00112	0.00513	CcSEcCtD
Duloxetine—Tension—Hyoscyamine—pancreatitis	0.0011	0.00504	CcSEcCtD
Duloxetine—Dysgeusia—Hyoscyamine—pancreatitis	0.0011	0.00503	CcSEcCtD
Duloxetine—Nervousness—Hyoscyamine—pancreatitis	0.00109	0.00499	CcSEcCtD
Duloxetine—Nausea—Propantheline—pancreatitis	0.00106	0.00487	CcSEcCtD
Duloxetine—Vision blurred—Hyoscyamine—pancreatitis	0.00106	0.00484	CcSEcCtD
Duloxetine—Agitation—Hyoscyamine—pancreatitis	0.00103	0.00472	CcSEcCtD
Duloxetine—Angioedema—Hyoscyamine—pancreatitis	0.00102	0.0047	CcSEcCtD
Duloxetine—Vertigo—Hyoscyamine—pancreatitis	0.00101	0.00462	CcSEcCtD
Duloxetine—Syncope—Hyoscyamine—pancreatitis	0.001	0.00461	CcSEcCtD
Duloxetine—Palpitations—Hyoscyamine—pancreatitis	0.000989	0.00454	CcSEcCtD
Duloxetine—Loss of consciousness—Hyoscyamine—pancreatitis	0.000984	0.00452	CcSEcCtD
Duloxetine—Convulsion—Hyoscyamine—pancreatitis	0.00097	0.00445	CcSEcCtD
Duloxetine—Chest pain—Hyoscyamine—pancreatitis	0.000953	0.00437	CcSEcCtD
Duloxetine—Anxiety—Hyoscyamine—pancreatitis	0.00095	0.00436	CcSEcCtD
Duloxetine—Dry mouth—Hyoscyamine—pancreatitis	0.000932	0.00428	CcSEcCtD
Duloxetine—Confusional state—Hyoscyamine—pancreatitis	0.000921	0.00423	CcSEcCtD
Duloxetine—Oedema—Hyoscyamine—pancreatitis	0.000914	0.00419	CcSEcCtD
Duloxetine—Anaphylactic shock—Hyoscyamine—pancreatitis	0.000914	0.00419	CcSEcCtD
Duloxetine—Shock—Hyoscyamine—pancreatitis	0.000899	0.00413	CcSEcCtD
Duloxetine—Tachycardia—Hyoscyamine—pancreatitis	0.000892	0.00409	CcSEcCtD
Duloxetine—Hyperhidrosis—Hyoscyamine—pancreatitis	0.000883	0.00405	CcSEcCtD
Duloxetine—Insomnia—Hyoscyamine—pancreatitis	0.000826	0.00379	CcSEcCtD
Duloxetine—Somnolence—Hyoscyamine—pancreatitis	0.000812	0.00373	CcSEcCtD
Duloxetine—Dyspepsia—Hyoscyamine—pancreatitis	0.000804	0.00369	CcSEcCtD
Duloxetine—Fatigue—Hyoscyamine—pancreatitis	0.000788	0.00362	CcSEcCtD
Duloxetine—Pain—Hyoscyamine—pancreatitis	0.000781	0.00359	CcSEcCtD
Duloxetine—Constipation—Hyoscyamine—pancreatitis	0.000781	0.00359	CcSEcCtD
Duloxetine—Feeling abnormal—Hyoscyamine—pancreatitis	0.000753	0.00346	CcSEcCtD
Duloxetine—Gastrointestinal pain—Hyoscyamine—pancreatitis	0.000747	0.00343	CcSEcCtD
Duloxetine—Urticaria—Hyoscyamine—pancreatitis	0.000726	0.00333	CcSEcCtD
Duloxetine—Abdominal pain—Hyoscyamine—pancreatitis	0.000722	0.00332	CcSEcCtD
Duloxetine—Body temperature increased—Hyoscyamine—pancreatitis	0.000722	0.00332	CcSEcCtD
Duloxetine—Hypersensitivity—Hyoscyamine—pancreatitis	0.000673	0.00309	CcSEcCtD
Duloxetine—Asthenia—Hyoscyamine—pancreatitis	0.000656	0.00301	CcSEcCtD
Duloxetine—Pruritus—Hyoscyamine—pancreatitis	0.000647	0.00297	CcSEcCtD
Duloxetine—Diarrhoea—Hyoscyamine—pancreatitis	0.000625	0.00287	CcSEcCtD
Duloxetine—Dizziness—Hyoscyamine—pancreatitis	0.000604	0.00277	CcSEcCtD
Duloxetine—Vomiting—Hyoscyamine—pancreatitis	0.000581	0.00267	CcSEcCtD
Duloxetine—Rash—Hyoscyamine—pancreatitis	0.000576	0.00264	CcSEcCtD
Duloxetine—Dermatitis—Hyoscyamine—pancreatitis	0.000576	0.00264	CcSEcCtD
Duloxetine—Headache—Hyoscyamine—pancreatitis	0.000572	0.00263	CcSEcCtD
Duloxetine—Nausea—Hyoscyamine—pancreatitis	0.000543	0.00249	CcSEcCtD
Duloxetine—Fluoxetine—HTR2A—pancreatitis	0.00052	0.0536	CrCbGaD
Duloxetine—Fluoxetine—ALB—pancreatitis	0.000356	0.0367	CrCbGaD
Duloxetine—Atomoxetine—HTR2A—pancreatitis	0.000334	0.0344	CrCbGaD
Duloxetine—HTR2A—Signaling by GPCR—MTNR1B—pancreatitis	6.28e-05	0.000461	CbGpPWpGaD
Duloxetine—HTR2A—Signaling by GPCR—CNR2—pancreatitis	6.12e-05	0.00045	CbGpPWpGaD
Duloxetine—HTR2A—Signaling by GPCR—TACR1—pancreatitis	6.12e-05	0.00045	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—FGG—pancreatitis	6.08e-05	0.000447	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—SCT—pancreatitis	6.08e-05	0.000447	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—CASR—pancreatitis	6.08e-05	0.000447	CbGpPWpGaD
Duloxetine—HTR2C—GPCR downstream signaling—SST—pancreatitis	6.03e-05	0.000443	CbGpPWpGaD
Duloxetine—HTR2A—Signaling by GPCR—CCKAR—pancreatitis	6.02e-05	0.000442	CbGpPWpGaD
Duloxetine—HTR2A—Class A/1 (Rhodopsin-like receptors)—CCL2—pancreatitis	6e-05	0.000441	CbGpPWpGaD
Duloxetine—HTR2C—Signaling by GPCR—PTHLH—pancreatitis	5.99e-05	0.00044	CbGpPWpGaD
Duloxetine—HTR2C—Signaling by GPCR—SMO—pancreatitis	5.99e-05	0.00044	CbGpPWpGaD
Duloxetine—NPY1R—Signaling Pathways—INS—pancreatitis	5.97e-05	0.000439	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—CX3CL1—pancreatitis	5.96e-05	0.000438	CbGpPWpGaD
Duloxetine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—pancreatitis	5.92e-05	0.000435	CbGpPWpGaD
Duloxetine—NPY1R—Signaling Pathways—CCL2—pancreatitis	5.87e-05	0.000431	CbGpPWpGaD
Duloxetine—HTR6—GPCR downstream signaling—CCL5—pancreatitis	5.86e-05	0.000431	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—MTNR1B—pancreatitis	5.8e-05	0.000426	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—CCK—pancreatitis	5.8e-05	0.000426	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—PPY—pancreatitis	5.79e-05	0.000426	CbGpPWpGaD
Duloxetine—HTR2A—SIDS Susceptibility Pathways—TNF—pancreatitis	5.76e-05	0.000424	CbGpPWpGaD
Duloxetine—HTR2A—GPCR downstream signaling—PTHLH—pancreatitis	5.73e-05	0.000421	CbGpPWpGaD
Duloxetine—HTR2C—Signaling by GPCR—PPP3CA—pancreatitis	5.71e-05	0.00042	CbGpPWpGaD
Duloxetine—HTR2C—GPCR downstream signaling—BDKRB2—pancreatitis	5.67e-05	0.000417	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—A2M—pancreatitis	5.65e-05	0.000415	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—CNR2—pancreatitis	5.65e-05	0.000415	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—TACR1—pancreatitis	5.65e-05	0.000415	CbGpPWpGaD
Duloxetine—HTR6—GPCR ligand binding—CXCL8—pancreatitis	5.65e-05	0.000415	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—PNLIP—pancreatitis	5.61e-05	0.000412	CbGpPWpGaD
Duloxetine—HTR2C—GPCR downstream signaling—CNR1—pancreatitis	5.57e-05	0.000409	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—CCKAR—pancreatitis	5.56e-05	0.000409	CbGpPWpGaD
Duloxetine—CYP2D6—Metabolism—CTRB2—pancreatitis	5.53e-05	0.000407	CbGpPWpGaD
Duloxetine—HTR2C—Signaling by GPCR—SST—pancreatitis	5.48e-05	0.000403	CbGpPWpGaD
Duloxetine—HTR2C—Class A/1 (Rhodopsin-like receptors)—CXCL8—pancreatitis	5.46e-05	0.000401	CbGpPWpGaD
Duloxetine—NPY1R—Signaling by GPCR—KRAS—pancreatitis	5.42e-05	0.000399	CbGpPWpGaD
Duloxetine—HTR2C—GPCR downstream signaling—GCG—pancreatitis	5.38e-05	0.000395	CbGpPWpGaD
Duloxetine—HTR6—Signaling by GPCR—CCL5—pancreatitis	5.32e-05	0.000391	CbGpPWpGaD
Duloxetine—HTR2C—GPCR ligand binding—CCL2—pancreatitis	5.26e-05	0.000387	CbGpPWpGaD
Duloxetine—HTR2A—GPCR downstream signaling—SST—pancreatitis	5.24e-05	0.000385	CbGpPWpGaD
Duloxetine—HTR2A—Signaling by GPCR—PTHLH—pancreatitis	5.2e-05	0.000382	CbGpPWpGaD
Duloxetine—HTR2A—Signaling by GPCR—SMO—pancreatitis	5.2e-05	0.000382	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—FGA—pancreatitis	5.17e-05	0.00038	CbGpPWpGaD
Duloxetine—HTR6—GPCR downstream signaling—HTR2A—pancreatitis	5.17e-05	0.00038	CbGpPWpGaD
Duloxetine—HTR2C—GPCR downstream signaling—KNG1—pancreatitis	5.16e-05	0.000379	CbGpPWpGaD
Duloxetine—HTR2C—Signaling by GPCR—BDKRB2—pancreatitis	5.15e-05	0.000379	CbGpPWpGaD
Duloxetine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—pancreatitis	5.14e-05	0.000378	CbGpPWpGaD
Duloxetine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—pancreatitis	5.09e-05	0.000374	CbGpPWpGaD
Duloxetine—HTR2C—Signaling by GPCR—CNR1—pancreatitis	5.06e-05	0.000372	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G1B—pancreatitis	5.05e-05	0.000371	CbGpPWpGaD
Duloxetine—SLC6A3—Transmission across Chemical Synapses—HRAS—pancreatitis	5.04e-05	0.00037	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—PPY—pancreatitis	5.03e-05	0.00037	CbGpPWpGaD
Duloxetine—NPY1R—Signaling Pathways—MDM2—pancreatitis	4.96e-05	0.000365	CbGpPWpGaD
Duloxetine—HTR2A—Signaling by GPCR—PPP3CA—pancreatitis	4.96e-05	0.000365	CbGpPWpGaD
Duloxetine—HTR2A—GPCR downstream signaling—BDKRB2—pancreatitis	4.92e-05	0.000362	CbGpPWpGaD
Duloxetine—HTR2C—Signaling by GPCR—GCG—pancreatitis	4.88e-05	0.000359	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism of lipids and lipoproteins—A2M—pancreatitis	4.87e-05	0.000358	CbGpPWpGaD
Duloxetine—HTR2A—GPCR downstream signaling—CNR1—pancreatitis	4.83e-05	0.000355	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—PTHLH—pancreatitis	4.8e-05	0.000353	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—SMO—pancreatitis	4.8e-05	0.000353	CbGpPWpGaD
Duloxetine—CYP2D6—Metabolism—FDX1—pancreatitis	4.8e-05	0.000353	CbGpPWpGaD
Duloxetine—HTR2A—Signaling by GPCR—SST—pancreatitis	4.76e-05	0.00035	CbGpPWpGaD
Duloxetine—HTR2A—Class A/1 (Rhodopsin-like receptors)—CXCL8—pancreatitis	4.74e-05	0.000349	CbGpPWpGaD
Duloxetine—SLC6A2—Transmembrane transport of small molecules—ALB—pancreatitis	4.71e-05	0.000346	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—FGB—pancreatitis	4.7e-05	0.000346	CbGpPWpGaD
Duloxetine—HTR6—Signaling by GPCR—HTR2A—pancreatitis	4.69e-05	0.000345	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—CTRB2—pancreatitis	4.69e-05	0.000345	CbGpPWpGaD
Duloxetine—HTR2C—Signaling by GPCR—KNG1—pancreatitis	4.69e-05	0.000344	CbGpPWpGaD
Duloxetine—HTR2A—GPCR downstream signaling—GCG—pancreatitis	4.67e-05	0.000343	CbGpPWpGaD
Duloxetine—HTR2A—SIDS Susceptibility Pathways—IL6—pancreatitis	4.65e-05	0.000342	CbGpPWpGaD
Duloxetine—NPY1R—Signaling Pathways—CXCL8—pancreatitis	4.64e-05	0.000341	CbGpPWpGaD
Duloxetine—NPY1R—Signaling by GPCR—HRAS—pancreatitis	4.61e-05	0.000339	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—PPP3CA—pancreatitis	4.58e-05	0.000337	CbGpPWpGaD
Duloxetine—HTR2A—GPCR ligand binding—CCL2—pancreatitis	4.57e-05	0.000336	CbGpPWpGaD
Duloxetine—HTR2A—GPCR downstream signaling—KNG1—pancreatitis	4.48e-05	0.000329	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—FGG—pancreatitis	4.48e-05	0.000329	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—CASR—pancreatitis	4.48e-05	0.000329	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—SCT—pancreatitis	4.48e-05	0.000329	CbGpPWpGaD
Duloxetine—HTR2A—Signaling by GPCR—BDKRB2—pancreatitis	4.47e-05	0.000329	CbGpPWpGaD
Duloxetine—CYP2D6—Metabolism—ADH4—pancreatitis	4.46e-05	0.000328	CbGpPWpGaD
Duloxetine—NPY1R—Signaling Pathways—CASP3—pancreatitis	4.44e-05	0.000326	CbGpPWpGaD
Duloxetine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—pancreatitis	4.42e-05	0.000325	CbGpPWpGaD
Duloxetine—NPY1R—Signaling by GPCR—IL6—pancreatitis	4.41e-05	0.000324	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—SST—pancreatitis	4.39e-05	0.000323	CbGpPWpGaD
Duloxetine—HTR2A—Signaling by GPCR—CNR1—pancreatitis	4.39e-05	0.000323	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—CX3CL1—pancreatitis	4.39e-05	0.000323	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—DUSP6—pancreatitis	4.36e-05	0.00032	CbGpPWpGaD
Duloxetine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—pancreatitis	4.33e-05	0.000318	CbGpPWpGaD
Duloxetine—HTR2C—GPCR downstream signaling—CCL5—pancreatitis	4.31e-05	0.000317	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—MTNR1B—pancreatitis	4.27e-05	0.000314	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—CCK—pancreatitis	4.27e-05	0.000314	CbGpPWpGaD
Duloxetine—HTR2A—Signaling by GPCR—GCG—pancreatitis	4.24e-05	0.000312	CbGpPWpGaD
Duloxetine—CYP2D6—Metabolism—PRSS1—pancreatitis	4.19e-05	0.000308	CbGpPWpGaD
Duloxetine—SLC6A3—Transmembrane transport of small molecules—ALB—pancreatitis	4.17e-05	0.000306	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—CNR2—pancreatitis	4.16e-05	0.000306	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—A2M—pancreatitis	4.16e-05	0.000306	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—TACR1—pancreatitis	4.16e-05	0.000306	CbGpPWpGaD
Duloxetine—HTR2C—GPCR ligand binding—CXCL8—pancreatitis	4.16e-05	0.000306	CbGpPWpGaD
Duloxetine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—pancreatitis	4.14e-05	0.000305	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—BDKRB2—pancreatitis	4.13e-05	0.000304	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—CCKAR—pancreatitis	4.09e-05	0.000301	CbGpPWpGaD
Duloxetine—HTR2A—Signaling by GPCR—KNG1—pancreatitis	4.07e-05	0.000299	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—FDX1—pancreatitis	4.06e-05	0.000299	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—CNR1—pancreatitis	4.06e-05	0.000298	CbGpPWpGaD
Duloxetine—CYP2D6—Metabolism—PRSS3—pancreatitis	3.98e-05	0.000292	CbGpPWpGaD
Duloxetine—CYP2D6—Metabolism—PNLIP—pancreatitis	3.98e-05	0.000292	CbGpPWpGaD
Duloxetine—HTR2C—Signaling by GPCR—CCL5—pancreatitis	3.92e-05	0.000288	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—GCG—pancreatitis	3.92e-05	0.000288	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—SCT—pancreatitis	3.89e-05	0.000286	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—FGG—pancreatitis	3.89e-05	0.000286	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—CASR—pancreatitis	3.89e-05	0.000286	CbGpPWpGaD
Duloxetine—SLC6A3—Neuronal System—HRAS—pancreatitis	3.86e-05	0.000284	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—CX3CL1—pancreatitis	3.81e-05	0.00028	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—FGA—pancreatitis	3.81e-05	0.00028	CbGpPWpGaD
Duloxetine—HTR2C—GPCR downstream signaling—HTR2A—pancreatitis	3.8e-05	0.00028	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—ADH4—pancreatitis	3.78e-05	0.000278	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—KNG1—pancreatitis	3.76e-05	0.000276	CbGpPWpGaD
Duloxetine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—pancreatitis	3.76e-05	0.000276	CbGpPWpGaD
Duloxetine—HTR2A—GPCR downstream signaling—CCL5—pancreatitis	3.75e-05	0.000275	CbGpPWpGaD
Duloxetine—NPY1R—Signaling Pathways—NRAS—pancreatitis	3.72e-05	0.000274	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—MTNR1B—pancreatitis	3.71e-05	0.000273	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—CCK—pancreatitis	3.71e-05	0.000273	CbGpPWpGaD
Duloxetine—HTR6—Signaling by GPCR—CCL2—pancreatitis	3.67e-05	0.000269	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—CNR2—pancreatitis	3.61e-05	0.000266	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—A2M—pancreatitis	3.61e-05	0.000266	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—TACR1—pancreatitis	3.61e-05	0.000266	CbGpPWpGaD
Duloxetine—HTR2A—GPCR ligand binding—CXCL8—pancreatitis	3.61e-05	0.000265	CbGpPWpGaD
Duloxetine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—pancreatitis	3.6e-05	0.000264	CbGpPWpGaD
Duloxetine—CYP2D6—Metabolism—XDH—pancreatitis	3.57e-05	0.000262	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—CCKAR—pancreatitis	3.55e-05	0.000261	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—PRSS1—pancreatitis	3.55e-05	0.000261	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—SMO—pancreatitis	3.54e-05	0.00026	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—PTHLH—pancreatitis	3.54e-05	0.00026	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—FGB—pancreatitis	3.46e-05	0.000254	CbGpPWpGaD
Duloxetine—NPY1R—Signaling Pathways—TGFB1—pancreatitis	3.46e-05	0.000254	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—PDGFA—pancreatitis	3.46e-05	0.000254	CbGpPWpGaD
Duloxetine—HTR2C—Signaling by GPCR—HTR2A—pancreatitis	3.45e-05	0.000254	CbGpPWpGaD
Duloxetine—HTR2A—Signaling by GPCR—CCL5—pancreatitis	3.4e-05	0.00025	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—PPP3CA—pancreatitis	3.38e-05	0.000248	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—PRSS3—pancreatitis	3.37e-05	0.000248	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—PNLIP—pancreatitis	3.37e-05	0.000248	CbGpPWpGaD
Duloxetine—CYP2D6—Metabolism—ADH1B—pancreatitis	3.33e-05	0.000244	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—FGA—pancreatitis	3.3e-05	0.000243	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—SST—pancreatitis	3.24e-05	0.000238	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—DUSP6—pancreatitis	3.21e-05	0.000236	CbGpPWpGaD
Duloxetine—NPY1R—Signaling Pathways—KRAS—pancreatitis	3.2e-05	0.000236	CbGpPWpGaD
Duloxetine—HTR6—GPCR downstream signaling—CXCL8—pancreatitis	3.19e-05	0.000235	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—CCL5—pancreatitis	3.14e-05	0.000231	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—LPL—pancreatitis	3.07e-05	0.000226	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—PTHLH—pancreatitis	3.07e-05	0.000226	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—SMO—pancreatitis	3.07e-05	0.000226	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—BDKRB2—pancreatitis	3.04e-05	0.000224	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—XDH—pancreatitis	3.02e-05	0.000222	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—FGB—pancreatitis	3.01e-05	0.000221	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—CNR1—pancreatitis	2.99e-05	0.00022	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—PPP3CA—pancreatitis	2.93e-05	0.000215	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—SPP1—pancreatitis	2.91e-05	0.000214	CbGpPWpGaD
Duloxetine—HTR6—Signaling by GPCR—CXCL8—pancreatitis	2.9e-05	0.000213	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—GCG—pancreatitis	2.88e-05	0.000212	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—ADH1B—pancreatitis	2.82e-05	0.000207	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—SST—pancreatitis	2.81e-05	0.000207	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—DUSP6—pancreatitis	2.79e-05	0.000205	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—HTR2A—pancreatitis	2.77e-05	0.000204	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—KNG1—pancreatitis	2.77e-05	0.000203	CbGpPWpGaD
Duloxetine—NPY1R—Signaling Pathways—HRAS—pancreatitis	2.72e-05	0.0002	CbGpPWpGaD
Duloxetine—HTR2C—Signaling by GPCR—CCL2—pancreatitis	2.7e-05	0.000198	CbGpPWpGaD
Duloxetine—CYP2D6—Metabolism—PLA2G1B—pancreatitis	2.65e-05	0.000195	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism of lipids and lipoproteins—LPL—pancreatitis	2.65e-05	0.000195	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—BDKRB2—pancreatitis	2.64e-05	0.000194	CbGpPWpGaD
Duloxetine—NPY1R—Signaling Pathways—IL6—pancreatitis	2.61e-05	0.000192	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—CNR1—pancreatitis	2.59e-05	0.000191	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—LEP—pancreatitis	2.58e-05	0.000189	CbGpPWpGaD
Duloxetine—CYP2D6—Metabolism—A2M—pancreatitis	2.56e-05	0.000188	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—PDGFA—pancreatitis	2.55e-05	0.000187	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—GCG—pancreatitis	2.5e-05	0.000184	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—KNG1—pancreatitis	2.4e-05	0.000177	CbGpPWpGaD
Duloxetine—HTR2C—GPCR downstream signaling—CXCL8—pancreatitis	2.35e-05	0.000173	CbGpPWpGaD
Duloxetine—HTR2A—Signaling by GPCR—CCL2—pancreatitis	2.34e-05	0.000172	CbGpPWpGaD
Duloxetine—CYP2D6—Metabolism—ALDH2—pancreatitis	2.34e-05	0.000172	CbGpPWpGaD
Duloxetine—HTR6—Signaling by GPCR—NRAS—pancreatitis	2.32e-05	0.000171	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—CCL5—pancreatitis	2.31e-05	0.00017	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—LPL—pancreatitis	2.26e-05	0.000166	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—PLA2G1B—pancreatitis	2.25e-05	0.000165	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—PDGFA—pancreatitis	2.21e-05	0.000162	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—INS—pancreatitis	2.2e-05	0.000162	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—A2M—pancreatitis	2.17e-05	0.00016	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—CCL2—pancreatitis	2.17e-05	0.000159	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—SPP1—pancreatitis	2.14e-05	0.000158	CbGpPWpGaD
Duloxetine—HTR2C—Signaling by GPCR—CXCL8—pancreatitis	2.13e-05	0.000157	CbGpPWpGaD
Duloxetine—HTR2A—GPCR downstream signaling—CXCL8—pancreatitis	2.04e-05	0.00015	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—HTR2A—pancreatitis	2.04e-05	0.00015	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—CCL5—pancreatitis	2.01e-05	0.000148	CbGpPWpGaD
Duloxetine—HTR6—Signaling by GPCR—KRAS—pancreatitis	2e-05	0.000147	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—ALDH2—pancreatitis	1.98e-05	0.000146	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—LPL—pancreatitis	1.97e-05	0.000144	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—pancreatitis	1.94e-05	0.000142	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—LEP—pancreatitis	1.9e-05	0.000139	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—SPP1—pancreatitis	1.86e-05	0.000137	CbGpPWpGaD
Duloxetine—HTR2A—Signaling by GPCR—CXCL8—pancreatitis	1.85e-05	0.000136	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—MDM2—pancreatitis	1.83e-05	0.000135	CbGpPWpGaD
Duloxetine—CYP2D6—Metabolism—GCG—pancreatitis	1.78e-05	0.000131	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—pancreatitis	1.74e-05	0.000128	CbGpPWpGaD
Duloxetine—HTR2C—Signaling by GPCR—NRAS—pancreatitis	1.71e-05	0.000126	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—CXCL8—pancreatitis	1.71e-05	0.000126	CbGpPWpGaD
Duloxetine—HTR6—Signaling by GPCR—HRAS—pancreatitis	1.7e-05	0.000125	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—LEP—pancreatitis	1.65e-05	0.000121	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—CASP3—pancreatitis	1.64e-05	0.00012	CbGpPWpGaD
Duloxetine—HTR6—Signaling by GPCR—IL6—pancreatitis	1.63e-05	0.00012	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—INS—pancreatitis	1.62e-05	0.000119	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—CCL2—pancreatitis	1.59e-05	0.000117	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—pancreatitis	1.52e-05	0.000112	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—GCG—pancreatitis	1.5e-05	0.000111	CbGpPWpGaD
Duloxetine—HTR2A—Signaling by GPCR—NRAS—pancreatitis	1.49e-05	0.000109	CbGpPWpGaD
Duloxetine—HTR2C—Signaling by GPCR—KRAS—pancreatitis	1.47e-05	0.000108	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—INS—pancreatitis	1.41e-05	0.000103	CbGpPWpGaD
Duloxetine—CYP2D6—Metabolism—LPL—pancreatitis	1.39e-05	0.000102	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—CCL2—pancreatitis	1.38e-05	0.000102	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—NRAS—pancreatitis	1.37e-05	0.000101	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—MDM2—pancreatitis	1.35e-05	9.91e-05	CbGpPWpGaD
Duloxetine—HTR2A—Signaling by GPCR—KRAS—pancreatitis	1.28e-05	9.41e-05	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—TGFB1—pancreatitis	1.28e-05	9.38e-05	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—CXCL8—pancreatitis	1.26e-05	9.27e-05	CbGpPWpGaD
Duloxetine—HTR2C—Signaling by GPCR—HRAS—pancreatitis	1.25e-05	9.21e-05	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—CASP3—pancreatitis	1.21e-05	8.87e-05	CbGpPWpGaD
Duloxetine—HTR2C—Signaling by GPCR—IL6—pancreatitis	1.2e-05	8.81e-05	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—KRAS—pancreatitis	1.18e-05	8.69e-05	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—LPL—pancreatitis	1.18e-05	8.68e-05	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—MDM2—pancreatitis	1.17e-05	8.61e-05	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—CXCL8—pancreatitis	1.09e-05	8.05e-05	CbGpPWpGaD
Duloxetine—HTR2A—Signaling by GPCR—HRAS—pancreatitis	1.09e-05	7.99e-05	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—CASP3—pancreatitis	1.05e-05	7.7e-05	CbGpPWpGaD
Duloxetine—HTR2A—Signaling by GPCR—IL6—pancreatitis	1.04e-05	7.65e-05	CbGpPWpGaD
Duloxetine—CYP2D6—Metabolism—PPARG—pancreatitis	1.02e-05	7.48e-05	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—NRAS—pancreatitis	1.01e-05	7.43e-05	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—HRAS—pancreatitis	1e-05	7.39e-05	CbGpPWpGaD
Duloxetine—CYP2D6—Metabolism—INS—pancreatitis	9.98e-06	7.33e-05	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—IL6—pancreatitis	9.62e-06	7.07e-05	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—TGFB1—pancreatitis	9.4e-06	6.91e-05	CbGpPWpGaD
Duloxetine—CYP2D6—Metabolism—ALB—pancreatitis	9.15e-06	6.72e-05	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—NRAS—pancreatitis	8.78e-06	6.46e-05	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—KRAS—pancreatitis	8.7e-06	6.4e-05	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—PPARG—pancreatitis	8.62e-06	6.33e-05	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—INS—pancreatitis	8.45e-06	6.21e-05	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—TGFB1—pancreatitis	8.16e-06	6e-05	CbGpPWpGaD
Duloxetine—CYP2D6—Metabolism—PTGS2—pancreatitis	8e-06	5.88e-05	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—ALB—pancreatitis	7.75e-06	5.7e-05	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—KRAS—pancreatitis	7.56e-06	5.56e-05	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—HRAS—pancreatitis	7.4e-06	5.44e-05	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—IL6—pancreatitis	7.08e-06	5.21e-05	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—PTGS2—pancreatitis	6.78e-06	4.98e-05	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—HRAS—pancreatitis	6.43e-06	4.72e-05	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—IL6—pancreatitis	6.15e-06	4.52e-05	CbGpPWpGaD
